A new trading day began on Tuesday, with Evolent Health Inc (NYSE: EVH) stock price up 2.30% from the previous day of trading ,before settling in for the closing price of $30.50. EVH’s price has ranged from $23.33 to $36.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 27.32%. Meanwhile, its annual earnings per share averaged 23.81%. With a float of $109.55 million, this company’s outstanding shares have now reached $113.89 million.
The extent of productivity of a business whose workforce counts for 4700 workers is very important to gauge.
Evolent Health Inc (EVH) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of Evolent Health Inc is 5.09%, while institutional ownership is 110.33%. The most recent insider transaction that took place on Dec 05 ’23, was worth 3,741,475. In this transaction Chief Executive Officer of this company sold 141,000 shares at a rate of $26.54, taking the stock ownership to the 637,645 shares. Before that another transaction happened on Nov 15 ’23, when Company’s PRESIDENT sold 11,000 for $30.00, making the entire transaction worth $330,000. This insider now owns 198,333 shares in total.
Evolent Health Inc (EVH) Performance Highlights and Predictions
In its latest quarterly report, released on 12/30/2023, the company reported earnings of $0.23 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to -13.43% drop over the previous five years of trading.
Evolent Health Inc (NYSE: EVH) Trading Performance Indicators
Here are Evolent Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.83. Likewise, its price to free cash flow for the trailing twelve months is 31.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit 0.23 in the next quarter and is forecasted to reach 1.56 in one year’s time.
Technical Analysis of Evolent Health Inc (EVH)
The latest stats from [Evolent Health Inc, EVH] show that its last 5-days average volume of 0.8 million was inferior to 0.98 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.10%. Additionally, its Average True Range was 0.94.
During the past 100 days, Evolent Health Inc’s (EVH) raw stochastic average was set at 62.00%, which indicates a significant increase from 42.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.80% in the past 14 days, which was lower than the 40.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.88, while its 200-day Moving Average is $29.36. Now, the first resistance to watch is $31.88. This is followed by the second major resistance level at $32.55. The third major resistance level sits at $33.13. If the price goes on to break the first support level at $30.62, it is likely to go to the next support level at $30.04. Assuming the price breaks the second support level, the third support level stands at $29.36.
Evolent Health Inc (NYSE: EVH) Key Stats
With a market capitalization of 3.60 billion, the company has a total of 115,430K Shares Outstanding. Currently, annual sales are 1,964 M while annual income is -113,040 K. The company’s previous quarter sales were 556,060 K while its latest quarter income was -33,410 K.
